| # | Drug | Count |
|---|---|---|
| 0 | ATORVASTATIN CALCIUM | 11 |
| 1 | PREDNISONE | 10 |
| 2 | ROSUVASTATIN | 10 |
| 3 | EVOLOCUMAB | 9 |
| 4 | IMATINIB | 7 |
| 5 | ADALIMUMAB | 6 |
| 6 | INFLIXIMAB | 6 |
| 7 | METHOTREXATE | 6 |
| 8 | METHOTREXATE SODIUM | 6 |
| 9 | SIMVASTATIN | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VINBLASTINE SULFATE | 5 | 0.0025 |
| 1 | ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID | 1 | 0.0016 |
| 2 | AVALGLUCOSIDASE ALFA-NGPT | 1 | 0.0010 |
| 3 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 4 | RALTEGRAVIR | 3 | 0.0006 |
| 5 | BRODALUMAB | 1 | 0.0005 |
| 6 | BLEOMYCIN SULFATE | 5 | 0.0005 |
| 7 | DICLOFENAC SODIUM AND MISOPROSTOL | 3 | 0.0005 |
| 8 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0004 |
| 9 | DASATINIB | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 1 | PCSK9 Inhibitor [EPC] | 9 | 0.0003 |
| 2 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 3 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |
| 4 | Bile Acid Sequestrant [EPC] | 3 | 0.0002 |
| 5 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 6 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 7 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 8 | Prostaglandin E1 Analog [EPC] | 3 | 0.0002 |
| 9 | GLP-2 Analog [EPC] | 2 | 0.0001 |